Endotoxaemia: What the Research Says
Evidence from 27 peer-reviewed studies
What Professionals Should Know
- •Dexmedetomidine combined with reduced sevoflurane dosing may help preserve organ function and acid-base balance during emergency colic surgery in endotoxaemic horses
- •The transient haemodynamic depression after dexmedetomidine loading resolves with continued infusion, making it a viable option for high-risk anaesthetic cases
- •Note that these findings are from experimental endotoxaemia under controlled conditions; clinical applicability to naturally occurring colic requires further investigation
- •COX-2 selective NSAIDs may offer superior outcomes in SISO cases by preserving intestinal barrier function while controlling endotoxaemia-related inflammation
- •Choice of NSAID in colic cases with suspected endotoxaemia warrants consideration of COX selectivity, not just anti-inflammatory potency
- •This multicentre trial provides evidence to guide NSAID selection protocols in equine surgical colic cases
- •Ethyl pyruvate shows promise as a potential therapeutic intervention for horses with endotoxaemia-related colic, a condition with limited current treatment options
- •Results from rodent and swine studies suggest EP may improve survival and protect organ function, warranting clinical trials in horses
- •This research addresses a significant gap in equine colic management, where inflammatory cascade activation drives morbidity and mortality
- •While DMSO is commonly used clinically in horses, this study shows it provides minimal benefit in endotoxaemic cases, with only modest fever reduction at high doses
- •DMSO does not meaningfully improve other key parameters of endotoxaemia (inflammatory markers, metabolic derangements, white cell counts), so practitioners should not rely on it as a primary endotoxaemia treatment
- •Alternative or adjunctive therapies should be considered as primary interventions for managing equine endotoxaemia rather than DMSO monotherapy
- •Polymyxin B can be used as a therapeutic option for endotoxaemia in horses, with the advantage that it remains effective even when given after clinical signs appear
- •A dose of 5000 u/kg is more effective than 1000 u/kg for controlling fever, heart rate elevation, and inflammatory markers in endotoxic horses
- •While nephrotoxicity was not observed in this controlled study, caution is still warranted in horses with existing azotaemia or renal compromise before using polymyxin B
- •Measuring sCD14 alone is not yet reliable enough to diagnose endotoxaemia in clinical practice; continue relying on clinical signs (heart rate, PCV, lesion assessment)
- •LPS measurement by LAL assay appears unsuitable for identifying endotoxaemic horses in clinical settings
- •Better biomarkers are still needed for early detection of endotoxaemia in emergency horses
- •Clinical signs alone are unreliable for diagnosing endotoxaemia in colic cases—actual LPS detection occurs in less than one-third of colicky horses despite higher suspicion rates, so laboratory confirmation should guide treatment decisions
- •Detectable plasma endotoxin is a significant mortality predictor; horses with positive LPS results warrant intensive monitoring and aggressive supportive care
- •Packed cell volume elevation alongside colic may indicate endotoxaemia; combining clinical assessment with LPS testing and PCV monitoring improves prognostic accuracy
- •Horses with concurrent endotoxaemia and carbohydrate overload face dramatically elevated laminitis risk (5/8 affected); monitor closely during illness if pasture access or grain availability is unrestricted.
- •Insulin sensitivity decreases after carbohydrate overload regardless of endotoxin exposure, supporting strict carbohydrate restriction in laminitis-prone horses and during systemic illness.
- •Systemic inflammation from either endotoxin or carbohydrate overload alone increases laminitis susceptibility; the combination is synergistic and particularly dangerous.
- •Understanding the temporal kinetics of inflammatory cytokine expression helps interpret clinical responses to endotoxaemia in colic cases
- •Different cytokines have different peak expression times and recovery periods, which may inform the window for therapeutic intervention in endotoxic horses
- •IL-1β and IL-6 sustained elevation may be particularly important monitoring targets in managing horses with endotoxaemic episodes
- •Large colon resection and anastomosis can be considered in horses with compromised colon viability, with a reasonable expectation of ~58% survival to discharge in a mixed population
- •Monitor heart rate closely at 24 hours post-recovery as a key prognostic indicator; elevated rates suggest increased mortality risk
- •Be prepared to manage post-operative endotoxaemia, ileus, and peritonitis aggressively, as these complications significantly impact survival outcomes
- •Carbohydrate overload carries significant risk of acute laminitis; monitor high-risk horses for lameness within 48–56 hours post-incident
- •Plasma endotoxin measurement may help confirm endotoxaemia-related laminitis, though levels are variable and biphasic responses are common
- •Recognition of the 32–48 hour peak endotoxin window suggests critical intervention period for management of carbohydrate-induced laminitis
- •The Malecot catheter may offer a practical option for peritoneal lavage and drainage management in post-operative equine colic cases complicated by septic peritonitis, but should currently be considered experimental pending larger studies.
- •Continuous 24-hour critical care with peritoneal drainage was associated with recovery from severe endotoxaemia and circulatory shock in this case, suggesting aggressive peritoneal management may improve outcomes.
- •This technique warrants further investigation before routine adoption; consult current surgical guidelines and consider referral to centres experienced with advanced peritoneal management in equine colic.
- •Short-term endotoxaemia causes significant microcirculatory dysfunction in horses that persists despite conventional haemodynamic management with fluids and vasopressors
- •Clinical monitoring of blood pressure and heart rate alone is insufficient to assess microcirculatory adequacy during sepsis; regional tissue perfusion may remain compromised
- •Veterinarians managing endotoxaemic horses should recognise that normalising MAP does not guarantee restoration of organ microcirculation, suggesting need for additional interventions
- •Horses with colic and signs of endotoxaemia may develop muscle damage independent of trauma; elevated muscle enzymes warrant investigation for systemic endotoxic effects
- •Severe gastrointestinal disease (ulcerative colitis, obstruction) can cause systemic endotoxaemia leading to myonecrosis, which may contribute to poor recovery or secondary complications
- •Post-colic monitoring should include muscle enzyme assessment to identify endotoxin-induced myonecrosis, which may affect prognosis and rehabilitation
- •Monitor platelet counts closely in septic and endotoxaemic foals and horses with enterocolitis, as thrombocytopenia may precede distal limb thrombosis and necrosis.
- •Be aware that standard treatment protocols (antibiotics, NSAIDs, crystalloid fluids) alone do not prevent hypercoagulability in severe sepsis; consider adjunctive anticoagulation or plasma therapy in high-risk cases.
- •Sudden onset of distal limb necrosis in septic patients should raise suspicion for arterial thrombosis; early recognition is critical as prognosis is poor once clinical signs appear.
- •When managing endotoxaemic donkeys, monitor haemostatic function as it may be altered during the disease process
- •Meloxicam administration may provide clinical benefit in endotoxaemic donkeys, though its specific effects on coagulation parameters require further investigation
- •This research addresses a knowledge gap specific to donkeys, as haemostatic responses to endotoxaemia differ from other equids and require species-specific clinical consideration
- •Recognise ECoV in adult horses presenting with fever, depression, and anorexia; submit faecal samples for qPCR confirmation rather than relying on clinical signs alone
- •Implement strict biosecurity protocols including faecal-oral precautions, as no specific vaccine or immunoprophylactic measures are currently available for horses
- •Monitor for complications such as endotoxaemia and hyperammonaemia-associated encephalopathy in infected horses, as these significantly impact prognosis beyond the primary viral infection
- •Early recognition and prompt antimicrobial treatment are critical for sepsis outcomes; intensive care including fluid resuscitation, pressure support, and management of inflammation and coagulopathy are essential components of treatment
- •In neonatal foals, ensure adequate passive transfer of colostral antibodies to prevent sepsis; monitor for multiple concurrent conditions including arthritis and meningoencephalitis
- •In mature horses, investigate gastrointestinal disease as the primary source in septic cases, and be alert for secondary complications such as laminitis and coagulopathies that require specific management
- •Understanding PRR function helps explain why endotoxaemia and sepsis in horses involve a balance between beneficial immune activation and harmful systemic inflammation
- •PRR-targeted therapies may represent future treatment approaches to modulate excessive inflammatory responses in equine sepsis and endotoxaemia
- •Recognition of PRR mechanisms provides a biological framework for interpreting clinical signs and treatment responses in horses with systemic inflammatory conditions
- •Ethyl pyruvate is a novel anti-inflammatory agent that may have clinical potential for treating endotoxaemia-related conditions in horses with colic or sepsis, though clinical trials are still needed
- •This preliminary work provides a foundation for further investigation into therapeutic options for conditions with high morbidity and mortality in equine practice
- •Results from preclinical models in other species suggest mechanistic benefit, but efficacy and safety protocols specific to horses require additional study
- •Consider systemic lidocaine administration as an adjunct treatment to reduce inflammation and promote mucosal healing in horses post-colic surgery
- •Be cautious with flunixin meglumine use post-operatively as it may delay mucosal repair in ischaemic intestinal tissue
- •Preventing endotoxin translocation through improved mucosal recovery is critical to reducing post-operative colic mortality
- •Insulin resistance should be considered as a potential underlying factor in cases of laminitis, metabolic syndrome, and endotoxaemia; clinicians need better diagnostic tools to reliably assess insulin status
- •Body condition, nutritional management, and breeding/lactation status all significantly affect insulin sensitivity and should be evaluated when assessing metabolic health in individual horses
- •Current insulin testing has limitations; practitioners should be aware that tolerance testing and clamping techniques each have practical constraints and diagnostic accuracy considerations when selecting assessment methods
- •Rapid phospholipid emulsion infusion may offer a treatment option for endotoxaemic horses with potentially fewer complications than slower infusion protocols
- •This approach addresses a significant clinical problem as endotoxaemia currently carries a poor prognosis in equine practice
- •Verify current treatment protocols and safety parameters with your veterinary team before clinical application
- •Minimally invasive laparoscopic approaches can be offered as alternatives to traditional open surgery for various abdominal conditions, reducing recovery time and complications.
- •Post-operative management significantly impacts outcomes; consider using prokinetic agents for ileus prevention, polymyxin B for endotoxaemia, and adhesion-prevention strategies such as peritoneal lavage with indwelling drains.
- •Modern surgical materials and techniques including stapling devices and selective COX-2 inhibitors can improve safety and reduce complications in abdominal surgery cases.
- •Horses with acute endotoxaemia show altered digital vascular reactivity that may contribute to laminitis development through reduced blood flow and prothrombotic mechanisms
- •Digital endothelial dysfunction during the acute phase of endotoxaemia represents a potential therapeutic target to prevent or mitigate laminitis progression
- •The vascular changes occur rapidly (within 3 hours) and persist despite absence of histopathological changes, suggesting functional rather than structural vascular damage in early endotoxaemia
- •Understanding how bacterial endotoxins activate neutrophils may inform treatment strategies for endotoxaemic horses, particularly regarding anti-inflammatory interventions
- •The synergistic effect of LPS and fMLP on neutrophil activation suggests that targeting multiple pathways may be more effective than single-agent therapies in managing endotoxin-related disease
- •Proteinase release by activated neutrophils may contribute to tissue damage in endotoxaemia, suggesting potential benefit from proteinase inhibitor therapies
- •Endotoxaemic horses experience altered gastric acid secretion and electrolyte composition that may contribute to gastrointestinal complications during systemic infection
- •NSAIDs like phenylbutazone may provide some protection against endotoxin-induced changes in gastric secretion, though effects are partial
- •Understanding endotoxin effects on gastric function helps explain gastrointestinal dysfunction in colicky or septic horses and may guide supportive treatment strategies
Key Research Findings
Dexmedetomidine infusion with 50% sevoflurane dose reduction did not cause sustained negative effects on cardiac index or intestinal blood flow in endotoxaemic horses despite transient decreases after loading dose
Dexmedetomidine treatment resulted in significantly lower creatinine (115 vs 195 µmol/L) and preserved acid-base status (bicarbonate 29.7 vs 23 mmol/L, base excess 2.0 vs -5.3 mmol/L) compared to LPS controls
Sevoflurane requirements were reliably reduced by approximately 40% with dexmedetomidine infusion while maintaining stable plasma concentrations throughout the study period
Study compared COX-2 selective NSAID (firocoxib) versus non-selective NSAID (flunixin meglumine) in horses with SISO
Preclinical evidence suggests COX-2 selective NSAIDs promote more complete intestinal barrier recovery and reduce endotoxin permeability compared to flunixin meglumine
COX-1 inhibition by non-selective NSAIDs may compromise gut barrier function during endotoxaemia, whereas selective COX-2 inhibition preserves protective COX-1 effects
Ethyl pyruvate is an anti-inflammatory agent that modulates proinflammatory cytokine expression
EP improved survival and organ function in sepsis and gastrointestinal injury models in rodents and swine
Therapeutic efficacy of EP in endotoxaemic horses requires investigation
High-dose DMSO (1 g/kg) ameliorated LPS-induced fever, the only significant clinical parameter affected
DMSO at either dose (20 mg/kg or 1 g/kg) did not significantly affect LPS-induced changes in white blood cell counts, plasma TNF-alpha, blood lactate, or glucose concentrations
All horses receiving LPS developed endotoxaemia as evidenced by clinical signs, haemoconcentration, and leucopenia
Overall, DMSO had minimal effects on clinical signs of induced endotoxaemia in horses despite fever amelioration
Polymyxin B at 5000 u/kg administered before or after endotoxin significantly reduced fever, tachycardia, and serum TNF compared to saline controls
Polymyxin B was effective even when administered 30 minutes after endotoxin infusion began
Evidence Base
Cardiopulmonary function and intestinal blood flow in anaesthetised, experimentally endotoxaemic horses given a constant rate infusion of dexmedetomidine.
Hector Rachel C, Rezende Marlis L, Nelson Brad B et al. (2021) — Equine veterinary journal
Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
Ziegler A L, Freeman C K, Fogle C A et al. (2019) — Equine veterinary journal
Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses.
Jacobs C C, Holcombe S J, Cook V L et al. (2013) — Equine veterinary journal
Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse.
Kelmer G, Doherty T J, Elliott S et al. (2008) — Equine veterinary journal
Polymyxin B protects horses against induced endotoxaemia in vivo.
Barton M H, Parviainen A, Norton N (2004) — Equine veterinary journal
Comparison of lipopolysaccharides and soluble CD14 measurement between clinically endotoxaemic and nonendotoxaemic horses.
Fogle J, Jacob M, Blikslager A et al. (2017) — Equine veterinary journal
Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes.
Senior J M, Proudman C J, Leuwer M et al. (2011) — Equine veterinary journal
Effects of endotoxaemia and carbohydrate overload on glucose and insulin dynamics and the development of laminitis in horses.
Tóth F, Frank N, Chameroy K A et al. (2009) — Equine veterinary journal
Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo.
Nieto J E, MacDonald M H, Braim A E Poulin et al. (2009) — Equine veterinary journal
Large colon resection and anastomosis in horses: 52 cases (1996-2006).
Driscoll N, Baia P, Fischer A T et al. (2008) — Equine veterinary journal
Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis.
Sprouse, Garner, Green (1988) — Equine veterinary journal
Efficacy of Malecot catheter for peritoneal lavage and drainage in a horse with septic peritonitis
N. Alidadi, F. Saberi Afshar (2025) — Equine Veterinary Education
Changes in microcirculation variables in an acute endotoxaemic equine model.
Sauter, Steblaj, Kästner et al. (2025) — Equine veterinary journal
Myonecrosis in three horses with colic: evidence for endotoxic injury.
Valentine B A, Löhr C V (2007) — The Veterinary record
Acute thrombosis of limb arteries in horses with sepsis: five cases (1988-1998).
Brianceau P, Divers T J (2001) — Equine veterinary journal
Effect of experimentally induced endotoxaemia and meloxicam administration on the haemostatic system in donkeys.
Perez-Ecija Alejandro, Buzon-Cuevas Antonio, Cara Carlos Gonzalez-De et al. (2025) — Equine veterinary journal
Equine coronavirus: An emerging enteric virus of adult horses.
Pusterla N, Vin R, Leutenegger C et al. (2016) — Equine veterinary education
A review of equine sepsis.
Taylor S (2015) — Equine veterinary education
Pattern recognition receptors in equine endotoxaemia and sepsis.
Werners A H, Bryant C E (2012) — Equine veterinary journal
Preliminary safety and biological efficacy studies of ethyl pyruvate in normal mature horses.
Schroeder E L, Holcombe S J, Cook V L et al. (2011) — Equine veterinary journal
Show 7 more references
Attenuation of ischaemic injury in the equine jejunum by administration of systemic lidocaine.
Cook V L, Jones Shults J, McDowell M et al. (2008) — Equine veterinary journal
Factors affecting clinical assessment of insulin sensitivity in horses.
Firshman A M, Valberg S J (2007) — Equine veterinary journal
Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses.
Moore J N, Norton N, Barton M H et al. (2007) — Equine veterinary journal
Recent advances in equine abdominal surgery.
Smith C L, Dowling B A, Dart A J (2005) — Veterinary journal (London, England : 1997)
Effect of acute sublethal endotoxaemia on in vitro digital vascular reactivity in horses.
Zerpa, Vega, Vasquez et al. (2005) — Journal of veterinary medicine. A, Physiology, pathology, clinical medicine
Potentiation of the extracellular release of equine neutrophil elastase and alpha-1-proteinase inhibitor by a combination of two bacterial cell wall components: fMLP and LPS.
Dagleish M P, Brazil T J, Scudamore C L (2003) — Equine veterinary journal
Effects of lipopolysaccharide and phenylbutazone on gastric contents in the horse.
Doherty T J, Andrews F M, Blackford J T et al. (2003) — Equine veterinary journal